What is CVE-2023-0967?

CVE-2023-0967 is a medium-severity vulnerability in Imaworldhealth Bhima, classified under Authorization Bypass Through User-Controlled Key. CVSS score: 6.5/10. Published 2023-04-05.

How severe is CVE-2023-0967?

Medium severity. CVSS v3 base score is 6.5 out of 10.

Auth bypass in Imaworldhealth Bhima

CVE-2023-0967

Bhima version 1.27.0 allows an attacker authenticated with normal user permissions to view sensitive data of other application users and data that should only be viewed by the administrator. This is possible because the application is vulnerable to IDOR, it does not properly validate user permissions with respect to certain actions the user can perform.

Vulnerability class: IDOR (Insecure Direct Object Reference)

EPSS: 0.007 (48.3th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N.

Affected products

Imaworldhealth Bhima — versions 1.27.0
N/a Bhima — versions 1.27.0

Weakness classification (CWE)

CWE-639 — Authorization Bypass Through User-Controlled Key

References

help@fluidattacks.com (Product)
help@fluidattacks.com (Exploit)

Frequently asked questions

What is CVE-2023-0967?: CVE-2023-0967 is a medium-severity vulnerability in Imaworldhealth Bhima, classified under Authorization Bypass Through User-Controlled Key. CVSS score: 6.5/10. Published 2023-04-05.
How severe is CVE-2023-0967?: Medium severity. CVSS v3 base score is 6.5 out of 10.